STATUTORY AND NIH REQUIREMENTS AND RESERVED GOVERNMENT RIGHTS. 5.1 Prior to the First Commercial Sale, the Licensee agrees to provide the IC with reasonable quantities of Licensed Products or materials made through the Licensed Processes for the IC’s research use.
STATUTORY AND NIH REQUIREMENTS AND RESERVED GOVERNMENT RIGHTS. 5.1 (a) the IC reserves on behalf of the Government an irrevocable, nonexclusive, nontransferable, royalty-free license for the practice of all inventions licensed under the Licensed Patent Rights throughout the world by or on behalf of the Government and on behalf of any foreign government or international organization pursuant to any existing or future treaty or agreement to which the Government is a signatory. Prior to the First Commercial Sale, the Licensee agrees to provide the IC with reasonable quantities of the Licensed Products or materials made through the Licensed Processes for IC research use; and
STATUTORY AND NIH REQUIREMENTS AND RESERVED GOVERNMENT RIGHTS. 5.1 (a) the NIH reserves on behalf of the Government an irrevocable, nonexclusive, nontransferable, royalty-free license for the practice of all inventions licensed under the Licensed Patent Rights throughout the world by or on behalf of the Government and on behalf of any foreign government or international organization pursuant to any existing or future treaty or agreement to which the Government is a signatory. Prior to the First Commercial Sale, the Licensee agrees to provide the NIH with reasonable quantities of the Licensed Products or materials made through the Licensed Processes for NIH research use; and
STATUTORY AND NIH REQUIREMENTS AND RESERVED GOVERNMENT RIGHTS. 5.1 The IC
STATUTORY AND NIH REQUIREMENTS AND RESERVED GOVERNMENT RIGHTS. 5.1 (a) The NIH reserves on behalf of the Government an irrevocable, nonexclusive, nontransferable, royalty-free license for the practice of all inventions licensed under the Licensed Patent Rights throughout the world by or on behalf of the Government and on behalf of any foreign government or international organization pursuant to any existing or future treaty or agreement to which the Government is a signatory. Prior to the First Commercial Sale, the Licensee agrees to provide the NIH with reasonable quantities of Licensed Products or materials or procedures associated with the Licensed Products or materials made through the Licensed Processes for the NIH research use. Given the nature of the envisioned Licensed Products as personalized autologous cell therapy products, if any Licensed Products and/or materials made through the Licensed Processes are not available in reasonable quantities for NIH research use, they shall not be subject to the foregoing obligation; and
STATUTORY AND NIH REQUIREMENTS AND RESERVED GOVERNMENT RIGHTS. 5.1 (a)the NIH reserves on behalf of the Government an irrevocable, non-exclusive, non-transferable, royalty‑free license for the practice of all inventions licensed under the Licensed Patent Rights throughout the world by or on behalf of the Government and on behalf of any foreign government or international organization pursuant to any existing or future treaty or agreement to which the Government is a signatory; and
STATUTORY AND NIH REQUIREMENTS AND RESERVED GOVERNMENT RIGHTS. 5.1 Upon request and prior to the First Commercial Sale, the Licensee agrees to require the Sublicensee to provide NIAID with reasonable quantities of Licensed Products or materials made through the Licensed Processes for NIAID research use.
STATUTORY AND NIH REQUIREMENTS AND RESERVED GOVERNMENT RIGHTS. 5.1 Prior to the First Commercial Sale, at the NIAID’s reasonable request and to the extent available, the Licensee agrees to provide the NIAID with reasonable quantities of Licensed Products or materials made through the Licensed Processes not to exceed [***] per calendar year for the NIAID’s internal, pre-clinical research use only. NIAID may not transfer any Licensed Products pursuant to this Paragraph 5.1 to any organization, entity, or governmental agency other than NIAID without the prior written consent of Licensee.
STATUTORY AND NIH REQUIREMENTS AND RESERVED GOVERNMENT RIGHTS. (a) the NIH reserves on behalf of the Government an irrevocable, nonexclusive, nontransferable, royalty-free license for the practice of all inventions licensed under the Licensed Patent Rights throughout the world by or on behalf of the Government and on behalf of any foreign government or international organization pursuant to any existing or future treaty or agreement to which the Government is a signatory. Prior to the First Commercial Sale, the Licensee agrees to provide the NIH with reasonable quantities of the Licensed Products or materials made through the Licensed Processes for NIH research use, including pre-clinical and clinical studies undertaken at the NIH; and
STATUTORY AND NIH REQUIREMENTS AND RESERVED GOVERNMENT RIGHTS. 5.1 (a) the NIH reserves on behalf of the Government an irrevocable, nonexclusive, nontransferable, royalty-free license for the practice of all inventions licensed under the Licensed Patent Rights throughout the world by or on behalf of the Government and on behalf of any foreign government or international organization pursuant to any existing or future treaty or agreement to which the Government is a signatory. Prior to the First Commercial Sale, the Licensee agrees to provide the NIH with reasonable quantities of the Licensed Products or materials made through the Licensed Processes for NIH research use. Given the nature of the envisioned Licensed Products as personalized autologous cell therapy products, if any Licensed Products and/or materials made through the Licensed Processes are not available in reasonable quantities for NIH research use, they shall not be subject to the foregoing obligation; and A-286-2014 CONFIDENTIAL NIH Patent License Agreement--Exclusive Model 10-2005 (updated 8-2012) Page 6 of 31 Final Lion Biotechnologies, Inc. February 4, 2015 03424-0001 266294.2
